13F

Stock

Aclaris Therapeutics, Inc.

ACRS · held by 2 managers

Reported value

$102.5K

Holders

2

+0 new · −0 exited

Holders’ est. mark

$15.7K

Price effect on 2 books still in the name

Largest holder

$84.7K

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC68.3K$84.7K$13KCut−$100.1K
Marex Group plc14.4K$17.9K$2.74KAdded$2.74K

Positions as of Q1 2024. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.